Utility of Presepsin and Interferon-λ3 for Predicting Disease Severity and Clinical Outcomes in COVID-19 Patients

Utility of Presepsin and Interferon-λ3 for Predicting Disease Severity and Clinical Outcomes in COVID-19 Patients

We explored the utility of novel biomarkers, presepsin and interferon-λ3 (IFN-λ3), for predicting disease severity and clinical outcomes in hospitalized Coronavirus (COVID-19) patients. In a total of 55 patients (non-critical, <i>n</i> = 16; critical, <i>n</i> = 39), presepsi...

Full description

Bibliographic Details
Main Authors: Gun-Hyuk Lee, Mikyoung Park, Mina Hur, Hanah Kim, Seungho Lee, Hee-Won Moon, Yeo-Min Yun
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Diagnostics
Subjects:
presepsin
interferon-λ3
COVID-19
severity
in-hospital mortality
SOFA score
Online Access:https://www.mdpi.com/2075-4418/13/14/2372

Internet

https://www.mdpi.com/2075-4418/13/14/2372

Similar Items